109 related articles for article (PubMed ID: 16093554)
1. A liquid chromatography/mass spectrometry-based method for the selection of ATP competitive kinase inhibitors.
Khandekar SS; Feng B; Yi T; Chen S; Laping N; Bramson N
J Biomol Screen; 2005 Aug; 10(5):447-55. PubMed ID: 16093554
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of 5'-p-fluorosulfonylbenzoyl-2' (or 3')-(biotinyl)adenosine as an activity-based probe for protein kinases.
Ratcliffe SJ; Yi T; Khandekar SS
J Biomol Screen; 2007 Feb; 12(1):126-32. PubMed ID: 17166825
[TBL] [Abstract][Full Text] [Related]
3. 5'-(p-fluorosulfonylbenzoyl)-2'(or 3')-(methylanthraniloyl)adenosine, fluorescent affinity labels for adenine nucleotide binding sites: interaction with the kinase active site of the receptor for epidermal growth factor.
Scoggins RM; Summerfield AE; Stein RA; Guyer CA; Staros JV
Biochemistry; 1996 Jul; 35(28):9197-203. PubMed ID: 8703925
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
5. Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates.
Guenat S; Rouleau N; Bielmann C; Bedard J; Maurer F; Allaman-Pillet N; Nicod P; Bielefeld-Sévigny M; Beckmann JS; Bonny C; Bossé R; Roduit R
J Biomol Screen; 2006 Dec; 11(8):1015-26. PubMed ID: 17092917
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites.
Ohnuma S; Chufan E; Nandigama K; Jenkins LM; Durell SR; Appella E; Sauna ZE; Ambudkar SV
Biochemistry; 2011 May; 50(18):3724-35. PubMed ID: 21452853
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the ATP-binding domain of human fructosamine 3-kinase-related protein by affinity labelling with 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
Payne LS; Brown PM; Middleditch M; Baker E; Cooper GJ; Loomes KM
Biochem J; 2008 Dec; 416(2):281-8. PubMed ID: 18637789
[TBL] [Abstract][Full Text] [Related]
8. Affinity purification of proteins binding to kinase inhibitors immobilized on self-assembling monolayers.
Bantscheff M; Hobson S; Kuster B
Methods Mol Biol; 2012; 795():149-60. PubMed ID: 21960221
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
[TBL] [Abstract][Full Text] [Related]
10. Selective ion tracing and MSn analysis of peptide digests from FSBA-treated kinases for the analysis of protein ATP-binding sites.
Renzone G; Salzano AM; Arena S; D'Ambrosio C; Scaloni A
J Proteome Res; 2006 Aug; 5(8):2019-24. PubMed ID: 16889425
[TBL] [Abstract][Full Text] [Related]
11. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
Chuaqui C; Deng Z; Singh J
J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
[TBL] [Abstract][Full Text] [Related]
12. A fluorescence lifetime based binding assay to characterize kinase inhibitors.
Lebakken CS; Hee Chol Kang ; Vogel KW
J Biomol Screen; 2007 Sep; 12(6):828-41. PubMed ID: 17644772
[TBL] [Abstract][Full Text] [Related]
13. 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.
Traxler PM; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Med Chem; 1996 Jun; 39(12):2285-92. PubMed ID: 8691423
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase inhibitors.
Fischer PM; Endicott J; Meijer L
Prog Cell Cycle Res; 2003; 5():235-48. PubMed ID: 14593718
[TBL] [Abstract][Full Text] [Related]
15. Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase.
Mulabagal V; Calderón AI
Anal Chem; 2010 May; 82(9):3616-21. PubMed ID: 20394394
[TBL] [Abstract][Full Text] [Related]
16. Affinity labeling of the ATP-binding site of type II calmodulin-dependent protein kinase by 5'-p-fluorosulfonylbenzoyl adenosine.
King MM; Shell DJ; Kwiatkowski AP
Arch Biochem Biophys; 1988 Dec; 267(2):467-73. PubMed ID: 2850765
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A.
Hines AC; Cole PA
Bioorg Med Chem Lett; 2004 Jun; 14(11):2951-4. PubMed ID: 15125966
[TBL] [Abstract][Full Text] [Related]
18. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor.
Yim H; Lee YH; Lee CH; Lee SK
Planta Med; 1999 Feb; 65(1):9-13. PubMed ID: 10083837
[TBL] [Abstract][Full Text] [Related]
19. Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors.
Snow RJ; Abeywardane A; Campbell S; Lord J; Kashem MA; Khine HH; King J; Kowalski JA; Pullen SS; Roma T; Roth GP; Sarko CR; Wilson NS; Winters MP; Wolak JP; Cywin CL
Bioorg Med Chem Lett; 2007 Jul; 17(13):3660-5. PubMed ID: 17499505
[TBL] [Abstract][Full Text] [Related]
20. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
